Untitled Flashcards Set
MicroPara Lec - Finals
S.Y. 2024 - 2025 | Level I Midyear Term
CLICKABLE TABLE OF CONTENTS
WEEK 4
SPIROCHETE & SPIRALS 2
MISCELLANEOUS BACTERIA 7
RICKETTSIAE, CHLAMYDIA 10
MYCOLOGY 12
VIROLOGY 21
DISCLAIMER: These notes were based on the actual lectures from our CI’s. If ever there are
any typos, missing info (especially terms that were only said verbally), or errors, please
understand if some parts are incomplete or not fully accurate. Kindly use these as a guide
and refer to other learning materials for confirmation. 🙏
PAGE 1 #PASAR #RN2028 Lord Help Us Pass MICROPARA 〒▽〒MicroPara Lec - Finals
S.Y. 2024 - 2025 | Level I Midyear Term
PATHOGENIC SPIROCHETES: TREPONEMA
WEEK 4
TOPIC OVERVIEW: Long Exam 4 Coverage
23. Spirochete & Spirillum
24. Miscellaneous bacteria
25. Rickettsiae, Chlamydia
26. Mycology
27. Virology
CHARACTERISTICS
●
Microscopy: Thin, spiral organisms with 3 axial
filaments
●
Difficult to stain
●
Transverse fission
●
Best demonstrated in darkfield microscopy
TREPONEMA PALLIDUM SUBSP. PALLIDUM
23 SPIROCHETE & SPIRALS
SPIROCHETE
CHARACTERISTICS
●
Gram (-)
●
Motile, slender, helically coiled, & unicellular
organisms
●
Facultatively anaerobic or aerobic
●
Most distinctive property is the presence of axial
filaments (axial fibrils), which are responsible for
motility
PATHOGENIC SPIROCHETES
1. TREPONEMA
●
T. pallidum subsp. pallidum
●
T. pallidum subsp. pertenue
2. BORRELIA
●
B. recurrentis
●
B. burgdorferi
3. LEPTOSPIRA INTERROGANS
SPIRALS
CHARACTERISTICS
●
Gram negative
●
Motile, slender, rigid organism
●
Amphitrichous flagella
●
Microaerophilic
PATHOGENIC SPIRALS
1. CAMPYLOBACTER JEJUNI
2. SPIRILLUM MINUS
●
●
●
●
●
●
The causative agent of syphilis
Microaerophilic
It is killed rapidly at 42 °C
Remains viable in whole blood or plasma for at
least 24 hours
It can cross the placenta and an intact mucous
membrane, and spread throughout the body
Generation time: 30 hours
CLINICAL INFECTIONS
1. SYPHILIS
●
Aka: French disease, Italian disease, The Great
Pox. It is also known as the “great imitator”
●
Transmission: Sexual contact, vertical
transmission, skin contact with active lesion,
transfusion of fresh blood, injuries from
contaminated needle stick
●
Symptoms: Chancre, fever, sore throat, headache,
rashes, and gummas of the skin
●
STAGES OF SYPHILIS:
A. PRIMARY STAGE
○
It is characterized by the appearance of
hunterian or hard chancre, which is an
infectious primary lesion that is painless and
usually seen on the genitalia
○
It develops 10 to 90 days after infection
○
No systemic signs or symptoms are evident
in this stage
○
Stage 1: Painless sores form on genitals,
rectum, or mouth
B. SECONDARY SYPHILIS
○
It develops 2 to 10 weeks after primary
syphilis
○
Systemic involvement with the following
manifestations: Fever, sore throat,
headache, generalized lymphadenopathy,
skin rashes involving the palms and soles,
and mucosal lesions
○
Stage 2: Painless sore heals, and skin rash
forms
PAGE 2 #PASAR #RN2028 Lord Help Us Pass MICROPARA 〒▽〒MicroPara Lec - Finals
S.Y. 2024 - 2025 | Level I Midyear Term
C. LATENT STAGE
○
It is the period in which the disease is
subclinical but not necessarily dormant
○
It occurs within more than a year of infection
○
In this stage, diagnosis can be made only by
a serologic test
D. TERTIARY SYPHILIS
○
It is the tissue-destructive phase
○
It may develop 3 to 10 years following the
last evidence of secondary syphilis
○
Complications: Neurosyphilis,
Cardiovascular abnormalities, eye disease,
and granulomatous-like lesions (gummas)
2. CONGENITAL SYPHILIS
●
Transmission: placental
●
Possibilities:
○
Fetus may be aborted
○
Baby may be born dead
○
Born alive with syphilis
○
Born in apparently good health but showing
evidence of syphilis several weeks, months, or
years after
LABORATORY DIAGNOSIS
1. MICROSCOPIC EXAMINATION
●
Direct microscopic examination of exudates is
recommended
●
Definitive test: Dark field microscopy for the
observation of motility
●
Stains: Levaditi’s stain and Fontana-Tribondeau
stain
●
Direct detection in lesions: Fluorescein
isothiocyanate-labeled antibody (FITC)
2. SERODIAGNOSIS
●
Nontreponemal test: These tests detect
non-specific antibodies against lipoidal antigens,
which are released when T. pallidum damages host
cells
○
●
It is used to monitor the treatment of syphilis
○
Serodiagnostic tests: Rapid plasma regain
(RPR), Venereal disease research laboratory
(VDRL), Unheated serum regain (USR),
Toluidine red unheated serum test (TRUST),
and ELISA
Treponemal test: It detects the presence of
antibodies to treponemal antigens
○
There are 2 types of treponemal/specific test:
(1) Indirect fluorescent antibody test (FTA-ABS)
(2) Treponema pallidum particle agglutination
(TPPA)
TREATMENT BY STAGE (part gihapon ni sa
congenital syphilis)
1. Primary, Secondary, and Early Latent Syphilis:
Typically treated with a single dose of intramuscular
benzathine penicillin G.
2. Late Latent and Tertiary Syphilis: May require multiple
doses of penicillin, often given weekly for three weeks
3. Neurosyphilis, Ocular Syphilis, and Otosyphilis:
Require a longer course of intravenous antibiotics, often
10-14 days
TREPONEMA PALLIDUM SUBSP. PERTENUE
PAGE 3 ●
●
The causative agent of yaws or frambesia tropica
Acquired through direct contact with skin lesion
YAWS
●
●
A chronic infectious disease primarily affecting the
skin, bones, and cartilage, particularly in tropical
regions
Characterized by skin lesions and, if left untreated,
can lead to severe deformities
TYPES OF YAWS
1. PRIMARY YAWS
●
Characterized by a wart like thickening of the
epidermis, which becomes fibrous, cracks open,
bleeds easily, and discharges a serous fluid
●
This lesion typically develops 9-90 days (average of
21 days) after infection
●
It can be accompanied by swollen lymph nodes
near the lesion
2. SECONDARY YAWS
●
Characterized by a multiple raised yellow skin
lesions appear on various parts of the body
●
These lesions can be papular (raised, solid bumps)
or ulcerative (open sores)
●
Bone pain, especially at night, and swelling of the
joints may occur
●
This stage can last for months, with periods of
active lesions followed by healing
3. TERTIARY YAWS
●
A late stage of the yaws infection
●
It typically occurs 5 to 10 years after the initial
infection, in individuals who have not been treated
●
It is characterized by destructive lesions affecting
the skin, bones, and cartilage
TREATMENT (either of 2 antibiotics)
#PASAR #RN2028 Lord Help Us Pass MICROPARA 〒▽〒MicroPara Lec - Finals
S.Y. 2024 - 2025 | Level I Midyear Term
1. Azithromycin (single oral dose) at 30 mg/kg (maximum
2 gm) is the preferred choice in the WHO
2. Benzathine penicillin (single intramuscular dose) at
1.2 million units (adults) and 600,000 units (children)
For patients allergic to penicillin and azithromycin,
doxycycline 100mg (1 tab) orally, twice daily for 7 days
may be used
PATHOGENIC SPIROCHETES: BORRELIA
CHARACTERISTICS
●
Gram-negative, corkscrew-shaped spirochetes
●
Larger than Treponema species
VISUALIZATION
●
Dark-field microscopy
●
Wright or Giemsa stain
●
Difficult to visualize using Gram stain
●
Microaerophilic
BORRELIA RECURRENTIS
●
The causative agent of
louse-borne/epidemic/European relapsing fever
CLINICAL INFECTION
1. EPIDEMIC-RELAPSING FEVER
●
Causative agent: Borrelia recurrentis
●
Vector: Pediculus humanus corporis (body louse)
●
Reservoir: Human
●
A louse becomes infected when it feeds on a febrile
(feverish) patient with relapsing fever.
●
Intact lice do not transmit the infection.
●
Transmission occurs when the louse is crushed,
and Borrelia recurrentis from its hemocoel (body
cavity) enters the human body through intact skin or
mucous membranes.
●
Symptoms: High fever, Headache, Muscle and
joint pain, Nausea, Vomiting
TREATMENT
●
Antibiotics like tetracyclines, doxycycline,
erythromycin, or procaine penicillin G are
typically effective in treating relapsing fever
BORRELIA BURGDORFERI
●
●
●
The causative agent of lyme disease
Vector: Hard tick (Ixodes)
Transmission: Bite of the Ixodes
CLINICAL INFECTION
1. LYME DISEASE
●
An acute, recurring inflammatory infection involving
the large joints of knees
●
The hallmarks of infection are erythema migrans
(bull’s eye lesion on the skin) and swelling
●
STAGES OF LYME DISEASE:
A. FIRST STAGE
○
The presence of erythema migrans or red,
ringed-shaped lesion with a clear center or a
“bull’s eye like lesion” at the site of the tick
bite is diagnostic of lyme disease
B. SECOND STAGE
○
It may start weeks to months after infection
○
There is dissemination of the organism to
other parts of the body
○
Signs and symptoms: Neurologic disorders
and nerve palsy
C. THIRD STAGE
○
There is a presence of recurring chronic
arthritis (acrodermatitis chronica
atrophicans) that may continue for years
○
Infected individuals may also develop
demyelination of neurons with symptoms of
Alzheimer’s disease and multiple sclerosis
LABORATORY DIAGNOSIS
1. MICROSCOPIC EXAMINATION
●
Leptospira species can be stained with Giemsa or
Wright stain
●
Dark field microscopy can be used for the detection
of the organism in blood cultures after 2-3 weeks if
incubation
●
Relapsing fever
○
Specimen of choice: Peripheral blood
○
Giemsa or Wright Stain: blue-colored
●
Lyme disease
○
Specimen of choice: Blood, CSF, and biopsy
specimen
○
Warthin-Starry satin: Tissue section
○
Giemsa stain: Blood and CSF
2. CULTURE
●
Culture media: Barbour-Stoenner-Kelly medium or
Chick embryo
3. MOLECULAR TEST
PAGE 4 #PASAR #RN2028 Lord Help Us Pass MICROPARA 〒▽〒MicroPara Lec - Finals
S.Y. 2024 - 2025 | Level I Midyear Term
●
PCR is important in diagnosis of B. burgdorferi DNA
in urine
PATHOGENIC SPIROCHETES: LEPTOSPIRA
CHARACTERISTICS
●
Obligate aerobes
●
Tightly coiled and are highly motile with hooked
ends
●
They live in the limen of the renal tubules and shed
in the urine
●
Recommended animals for cultivation: Hamsters
and Guinea pigs
●
Generation time: 6 to 16 hours
LEPTOSPIRA INTERROGANS
●
This form of the illness is rarely fatal and represents
approximately 90% of all documented cases of
Leptospirosis
LABORATORY DIAGNOSIS
1. MICROSCOPIC EXAMINATION
●
Dark Field microscopy
2. CULTURE
●
Specimen of choice: Blood, CSF, and urine
specimens
●
Medium of choice: Fletcher’s medium, BMUH
medium, Bovine serum albumin, Stuart’s broth
TREATMENT
●
Antibiotics that may be used include doxycycline,
amoxicillin, or ampicillin
●
If the infection is severe, one may use intravenous
penicillin G, third-generation cephalosporins, or
erythromycin
●
●
●
The causative agent of leptospirosis
You can get leptospirosis after getting water or soil
contaminated by animal pee (urine) in your nose,
your mouth, your eyes or a break in your skin
Symptoms: fever, headache, myalgia, anorexia,
and vomiting
MODE OF ACQUISITION
1. Entry through breaks in the skin, mucous membranes or
conjunctiva
2. 3. Direct contact with the urine or carriers like rats
Contact with bodies of water that are contaminated with
the urine of the carriers
4. Upon entry, leptospira rapidly invade the bloodstream
and spread throughout CNS and kidneys
TYPES OF LEPTOSPIROSIS
1. ICTERIC OR WEIL SYNDROME
●
It is a severe form of illness that affects the liver and
kidneys, and cause vascular dysfunction
●
Symptoms: jaundice (yellowing of the skin and
eyes), kidney failure, liver failure, internal
hemorrhaging, and respiratory distress
●
Death occur in up to 10% of the cases
PATHOGENIC SPIRALS: CAMPYLOBACTER
JEJUNI
CHARACTERISTICS
●
Gram-negative bacterium
●
Curved, slender, motile rod
●
Microaerophilic bacterium
●
It is often transmitted from animals to humans, with
poultry being a major source of infection
●
Campylobacter bacteria are a common cause of
diarrheal illness. The illness is called
campylobacteriosis
●
People most commonly get Campylobacter infection
by eating raw or undercooked poultry
●
Eating other contaminated foods, drinking untreated
water, and touching animals that carry
Campylobacter can also cause infection
TREATMENT
●
Azithromycin therapy would be a primary
antibiotic choice for Campylobacter jejuni
gastroenteritis when indicated with a typical
regimen of 500 mg for 3 days
●
However, erythromycin is the classic antibiotic of
choice
2. ANICTERIC LEPTOSPIROSIS
●
This is the more common and less severe form of
leptospirosis
●
Symptoms: septicemic stage of infection, high
fever, and sever headache (3 to 7 days) followed by
immune stage
●
Hallmark of immune stage: Aseptic meningitis
PATHOGENIC SPIRALS: SPIRILLUM MINUS
PAGE 5 #PASAR #RN2028 Lord Help Us Pass MICROPARA 〒▽〒MicroPara Lec - Finals
S.Y. 2024 - 2025 | Level I Midyear Term
CHARACTERISTICS
●
A gram-negative helical-shaped bacillus commensal
organisms
●
The bacteria can be found in the oral, nasal, and
conjunctival secretions and animal urine
●
It can be transmitted to people through broken skin,
bites, or scratches
●
Infection can also result from close contact with an
infected rodent (without a bite of scratch)
CLINICAL INFECTIONS
1. STREPTOBACILLARY RAT-BITE FEVER
●
Incubation period: 1 to 22 (usually less than 7)
days, a viral-like syndrome develops abruptly,
causing chills, fever, vomiting, headache, and back
and joint pains
●
Most patients develop a morbilliform, petechial, or
vesicular rash on the hands and feet about 3 days
later
2. SEPTIC ARTHRITIS
●
Usually affecting the large joints asymmetrically,
develops in many patients within 1 week and, if
untreated, may persist for several days or months
●
Fever may return, occurring irregularly over a period
of weeks to months
TREATMENT
●
Is a 14-day course of antibiotics that usually begins
with an IV antibiotic for 6 to 7 days before
switching to an oral antibiotic
●
The IV antibiotic is usually one of the following:
○
Penicillin G 200,000 units every 4 hours
○
Ceftriaxone 1 g once a day
○
A higher dose of IV penicillin G may be
preferred for patients with severe disease
●
After 6 or 7 days, patients who have clinically
improved can be switched to one of the following
oral antibiotics to complete the 14-day course:
○
Amoxicillin 500 mg 3 times a day
○
Ampicillin 500 mg 4 times a day
○
Penicillin V 500 mg 4 times a day
Tabang ngano nag ka lisod namn ni
PAGE 6 #PASAR #RN2028 Lord Help Us Pass MICROPARA 〒▽〒MicroPara Lec - Finals
S.Y. 2024 - 2025 | Level I Midyear Term
24 MISCELLANEOUS BACTERIA
BACILLUS ANTHRACIS
CHARACTERISTICS
●
Aka: Anthrax bacillus
●
Largest pathogenic bacilli
●
Gram-positive
●
Rod-shaped
●
Non-motile bacteria
●
Halophilic organism (can withstand up to 7% of
sodium hypochlorite)
●
Endospore-forming pathogen
●
Can be grown under both aerobic and anaerobic
conditions
●
Not part of the indigenous human microbiota
CLINICAL INFECTION
ANTHRAX
●
The causative agent of anthrax is Bacillus
anthracis
●
Can cause severe illness in both humans and
animals
●
People usually get anthrax from infected animals or
even through contaminated animal products
TYPES OF ANTHRAX
1. CUTANEOUS ANTHRAX
●
The most common form of anthrax infection but also
considered to be the least dangerous
●
It is acquired through skin cuts and abrasions
●
A small papule appears at the site of the spore
inoculation 2 to 5 days after exposure
●
It is characterized by the appearance of a “black
eschar”, which is a black, necrotic and painless
central area that does not produce pus
2. PULMONARY ANTHRAX / WOOLSORTER’S
DISEASE
●
It is acquired when spores are inhaled into the
pulmonary parenchyma
●
It resembles an upper respiratory tract infection
●
Causes severe breathing problems and may lead to
death
●
Signs and symptoms: Mild fever, fatigue, malaise,
and dyspnea
3. GASTROINTESTINAL ANTHRAX
●
A rare but potentially fatal form of anthrax infection
●
●
caused by ingesting undercooked meat from an
infected animal. It can cause lesions and
inflammation from the throat to the colon
The bacteria usually affect the esophagus, throat,
stomach, and intestines
Signs and symptoms: Abdominal pain, nausea,
anorexia, vomiting, and bloody diarrhea
LABORATORY DIAGNOSIS
●
Specimen: Malignant pustule, sputum, and blood
●
Processing of samples for B. anthracis should be
done in a biological safety cabinet level 3
●
Spore stain: Malachite green and McFadyean stain
●
Direct Fluorescent Antibody Test: Diagnostic test
MANAGEMENT & TREATMENT
1. ANTIBIOTICS: Oral, injectable, or intravenous
antibiotics for 60 days. Commonly used antibiotics
include ciprofloxacin and doxycycline
2. ANTITOXINS: These injectable antibody medications
neutralize anthrax toxins in your body. Treatment
typically includes antibiotics too
3. VACCINE: A vaccine to prevent anthrax infection,
BioThrax, also treats infected people. Treatment
involves three doses of the vaccine over four weeks.
You’ll receive antibiotics at the same time
LISTERIA MONOCYTOGENES
PAGE 7 CHARACTERISTICS
●
Gram-positive
●
Rod-shaped
●
Peritrichous flagella
●
Catalase positive
●
Beta-hemolytic when grown on blood agar
●
Both a human and an animal pathogen
●
Halophilic organism
CLINICAL INFECTION
LISTERIOSIS
●
Listeria monocytogenes is the causative agent for
this infection
●
A serious infection that affects neonates, pregnant
women, and immunocompromised hosts
TYPES OF LISTERIOSIS
1. MATERNAL DISEASE (PREGNANCY)
●
It usually occurs during the third trimester of
pregnancy
●
It leads to miscarriage or stillbirth
#PASAR #RN2028 Lord Help Us Pass MICROPARA 〒▽〒MicroPara Lec - Finals
S.Y. 2024 - 2025 | Level I Midyear Term
●
Signs and symptoms: flu-like illness, fever,
headache, and myalgia
2. NEONATAL DISEASE
●
It is associated with an intrauterine infection due to
the aspiration of infected amniotic fluid
●
It leads to meningitis that is usually seen by the
third week of life
●
Mode of acquisition: transplacental & perinatal
3. DISEASE OF IMMUNOCOMPROMISED HOSTS
●
It develops through the ingestion of contaminated
dairy products and processed meat products
LABORATORY DIAGNOSIS
●
Specimen: Blood, CSF, and swab of lesions
●
Motility Test: Tumbling motility at RT
●
Culture: BAP, CAP, BHI
●
Biochemical Test:
○
Glucose fermentation (+)
○
Catalase (+)
○
Urease (-)
○
H2S production, Nitrate reduction (-)
MANAGEMENT & TREATMENT
1. ANTIBIOTICS: Ampicillin or penicillin G are the primary
choices for treating listeriosis. Gentamicin is often added
to enhance effectiveness, particularly for meningitis
2. NEONATAL INFECTIONS: In newborns, ampicillin
combined with an aminoglycoside (like gentamicin) is
the recommended treatment
○
thus resist water treatments
They cannot grow on routine primary plated
media like BAP
CLINICAL INFECTIONS
1. LEGIONNAIRES’ DISEASE
●
It is also known as legionellosis, which is febrile and
pneumonic illness
●
Mode of transmission: Airborne spread or inhalation
of infectious aerosols
●
Symptoms: High fever, non-productive cough,
headache, neurological, and severe
bronchopneumonia
2. PONTIAC FEVER
●
It is a non-fatal respiratory infection that resembles
an allergic disease but exhibits the symptoms of
pneumonia
3. WOUND ABSCESS & ENCEPHALITIS
Table 1: Comparison of Legionnaires’ Disease and
Pontiac Fever
Legionnaires’ Disease Pontiac Fever
Type of
Illness
●
●
●
●
Progressive
pneumonia
5-15% fatality rate
Treatment required
Highest fatality rate
in health care
facilities
●
●
●
Flu-like illness
Recovery in 2-5
days
Medical treatment
not necessary
LEGIONELLA PNEUMOPHILA
●
●
Symptoms
Infection
rate
Incubation CHARACTERISTICS
●
Gram negative
●
Bacillary or coccobacillary in form
●
Aerobic, motile
●
Non-carbohydrate fermenting
●
Major reservoirs: Hot water system, cooling
towers, and evaporative condensers
●
Serogroups: 1 to 7
●
Serogroups associated to the Legionnaires disease
1, 4, and 6
●
The distinguishing characteristics of Legionella
species are as follows:
○
They can infect and multiply within some
free-living amoeba, ciliated protozoa, and
biofilms
○
They can be isolated from lakes, rivers, hot
springs, and mud
○
They can tolerate up to 3 mg/L of chlorine and
PAGE 8 #PASAR #RN2028 Lord Help Us Pass MICROPARA 〒▽〒
Severe pneumonia
with chills and cough
Muscle aches,
headache, tiredness,
loss of appetite, and
diarrhea
●
●
Fever
Muscle aches
<5% of those exposed >95% of those exposed
2-10 days 36 hours
Risk
Factors
●
●
●
●
●
Smoking and lung
disorders
Diabetes, cancer,
and kidney disease
AIDS/HIV
Age older than 50
Heavy drinking
None knownMicroPara Lec - Finals
S.Y. 2024 - 2025 | Level I Midyear Term
LABORATORY DIAGNOSIS
●
Specimen: Sputum and bronchoalveolar lavage
●
Urine is an important specimen for antigen
detection
●
Culture media: BCYE with L-cysteine, ferric salt,
and alpha-ketoglutarate
●
Serologic Test: Indirect fluorescent antibody
●
Rapid methods: PCR test, Urine antigen test
MANAGEMENT & TREATMENT
1. ANTIBIOTICS
●
Fluoroquinolones (like levofloxacin or
moxifloxacin) and macrolides (like azithromycin)
are commonly used antibiotics for Legionnaires’
disease
●
Treatment typically lasts for 1 to 3 weeks, with a
longer duration (up to 3 weeks) sometimes
recommended for severely immunocompromised
patients
MANAGEMENT & TREATMENT
1. ANTIBIOTICS
●
Macrolides: Azithromycin, clarithromycin, and
erythromycin are commonly used macrolide
antibiotics for Mycoplasma pneumoniae infections
●
Tetracyclines: Doxycycline is an alternative for
macrolide-resistant infections, but is not
recommended for young children
●
Fluoroquinolones: These antibiotics may be used
if other treatments fail, but are generally not
recommended for children
MYCOPLASMA PNEUMONIAE
CHARACTERISTICS
●
Gram negative
●
Rod shaped bacteria
●
Lack cell wall
●
Fastidious
●
Facultative anaerobes
CLINICAL INFECTION
PRIMARY ATYPICAL PNEUMONIA
●
It occurs as separate incidents or as outbreaks in
closed populations such as in school, military
camps, and within family members
●
Mode of acquisition: Inhalation of contaminated
aerosol droplets
●
Symptoms: dry cough, fever, and mild shortness of
breath
LABORATORY DIAGNOSIS
●
Specimen: Throat swab, serum, bronchoalveolar
lavage, sputum & lung tissue, urethral, vaginal or
endocervical swab, blood, urine, prostatic
secretions and semen
●
Culture: SP4 broth
●
Serodiagnosis: ELISA
PAGE 9 #PASAR #RN2028 Lord Help Us Pass MICROPARA 〒▽〒MicroPara Lec - Finals
S.Y. 2024 - 2025 | Level I Midyear Term
25 RICKETTSIAE, CHLAMYDIA
RICKETTSIA
CHARACTERISTICS
●
The species of this genus have the simplest
bacterial form and are considered transitional
organisms between bacteria and viruses
●
Fastidious, obligate, intracellular organism
●
Mode of acquisition: Humans become infected ff
the bite of an infected arthropod vector
●
Accidental host: Humans
●
Agents of bioterrorism: R. prowazekii and R.
rickettsii
TRANSMISSION & SPREAD OF RICKETTSIA
1. The organisms gain access to humans through skin
abrasions or arthropod bites
2. The organisms are disseminated homogeneously, thus
causing vasculitis in the blood vessels
3. The members of the typhus group reproduce in the
cytoplasm cellular injury and death
4. Rickettsia felis is maintained transovarially in cat flea,
Ctenocephalides felis
RICKETTSIA: SPOTTED FEVER VS TYPHUS
GROUP
1. SPOTTED FEVER GROUP
●
Rocky mountain spotted fever (RMSF) is the most
serious rickettsial infection
●
For RMSF, humans are the accidental hosts and
ticks are the main vector and reservoir
●
The rashes develop on the palms of the hands and
soles of the feet of RMSF patients
2. TYPHUS GROUP
●
Epidemic typhus is characterized by rashes on the
face, palms, and soles of the feet of the sick
individual
●
Rashes are not commonly observed in patients with
endemic typhus
●
Inhalation of aerosol from dried infected flea feces
is also a mode of transmission of Rickettsia typhi
infection
ORIENTIA
ORIENTIA TSUTSUGAMUSHI
●
Aka: Scrub typhus
●
●
●
●
It belongs to the family of Rickettsiaceae
Transmitted through the bite of infected chigger
mite
Incubation period: 1-3 weeks
Clinical manifestation: fever, chills, sore throat,
myalgia, lymphadenopathy, generalized
maculopapular skin rashes, characteristic skin
lesion at the site of bite (eschar)
MANAGEMENT & TREATMENT
1. ANTIBIOTICS
●
Primary treatment of scrub typhus is doxycycline
until the patient improves, has been afebrile for 48
hours, and has received treatment for at least 7
days
●
For pregnant women and patients with severe
doxycycline allergy, azithromycin has been shown
to be a safe and effective alternative
CHLAMYDIA
CHARACTERISTICS
●
Gram negative
●
Small, non-motile
●
Obligate intracellular organisms
●
They do not possess cytochromes and cannot
synthesis their own ATP
●
Species: C. trachomatis, C. psittaci, C.
pneumoniae
TWO MORPHOLOGIC FORMS
RETICULATE BODY (RB) ELEMENTARY BODY (EB)
●
●
●
Replicative and
non-infectious form
It is the intracellular and
metabolically active form
It directs the
reproduction of host
cells to their own
metabolic needs so they
multiply by binary fission
●
●
●
●
It is the extracellular
form of Chlamydia and
is spherical in shape
It resemble Gram
negative bacilli with a
rigid cell wall
It infects the host cell by
inducing active
phagocytosis
Its 2 components are
the major outer
membrane protein and
lipopolysaccharide
antigen
CHLAMYDIA TRACHOMATIS
●
It is one of the major sexually transmitted
PAGE 10 #PASAR #RN2028 Lord Help Us Pass MICROPARA 〒▽〒MicroPara Lec - Finals
S.Y. 2024 - 2025 | Level I Midyear Term
●
●
●
●
pathogens
It is one of the principle causes of pelvic
inflammatory disease and ocular trachoma
It can travel through the birth canal where infants
can be infected during birth
It is associated with infertility and ectopic pregnancy
Natural host: Humans
CLINICAL INFECTION
1. TRACHOMA
●
It is a chronic inflammation of the conjunctiva that
leads to blindness
●
It can cause distortion of the eyelids
●
Mode of transmission: Contact with contaminated
objects, hand-to-hand contact with carriers, and
through vectors
2. LYMPHOGRANULOMA VENEREUM (LGV)
●
It is a sexually transmitted disease that has
multi-system involvement
●
A small, painless ulcer or papule appears initially,
and then nodules develop after several weeks
LABORATORY DIAGNOSIS
●
Specimen: Urethra and cervical secretions,
conjunctiva discharge, nasopharynx and rectal
swabs and materials aspirated from fallopian tubes
and epididymis
●
Culture: Buffalo green monkey cells, HeLa 229
cells, Hep-2 cells, McCoy cells, and
Cycloheximide-treated McCoy cells
●
Enzyme immunoassay: rapid antigen assay
MANAGEMENT & TREATMENT
1. ANTIBIOTICS
●
Azithromycin: A single 1-gram dose is often
prescribed
●
Doxycycline: Typically taken twice a day for 7 days
●
Other options: Tetracycline, erythromycin, or
ofloxacin may be used in certain situations
jk
PAGE 11 #PASAR #RN2028 Lord Help Us Pass MICROPARA 〒▽〒MicroPara Lec - Finals
S.Y. 2024 - 2025 | Level I Midyear Term
MOULDS
26 MYCOLOGY
Study of fungi
FUNGI
●
●
●
●
●
●
Microscopic eukaryotic organisms
First classified under kingdom Plantae, later
separately classified under Kingdom Fungi
○
Due to the presence of unique rigid cell
wall, which is chemically different from the
bacterial cell wall
○
Unlike plants, fungi are non photosynthetic
○
They have similar appearance with plants
(i.e., mushrooms)
80,000 species described: 400–medically
important, <50 responsible for more than 90%
of fungal infections of humans and animals
Fungal cell wall
○
Rich in carbohydrates: polymers of
acetylglucosamine “chitin”, forming a thick
layer protecting inner organelles from the
adverse external environment
Cell membrane
○
Contains ergosterol; organized nucleus more
often reproduce by asexual spores (but can
also produce sexually)
Produce multi-celled hyphae or single-celled
yeasts
●
Classified according to morphology and taxonomy
FUNGAL CELL WALL
●
Boxes =
antifungal drugs
●
Distinct about
fungi is the
presence of
CHITIN (plants
have no chitin
but cellulose)
●
Fungi look like
plants macroscopically, but look more like animal
kingdom microscopically (They are closely related
to animals than plants)
MORPHOLOGICAL CLASSIFICATION
COMMON TERMS
1. Hyphae: tubular-like structures that compose a mold
colony
2. Septae: cross walls present in some hyphae; singular:
septa
3. Nonseptate: lacking septa
4. Hyaline:
○
lacking pigment
○
molds do NOT have pigment; they are
colorless and transparent
5. Dematiaceous: containing dark pigment
6. Chlamydoconidia: large, round spores in or on hyphae
7. Conidia: asexual spores produced by molds with septa
8. Mycelium: a colony, made up of rope-like filaments
called hyphae
●
Hyphae: help in the interexchange of cytosol and
organelles between adjacent cells
●
May be septate or pauciseptate
9. Spores: Conidia
●
produced in a conidiophore
●
Macroconidia and/or microconidia (can be both or
either)
●
Spores or hyphae may be pigmented or not
Possible Structure of Mould Colony
●
Not all can be found in every fungal species
10. Chlamydospore: spores that grow on the hyphae itself
(circles)
11. Arthroconidia: bigger segments on the hyphae
compared to the septae
12. Sporangiospores: found in sporangia connected to the
hyphae
●
Conidia are connected to the conidiophore
connected to the hyphae
13. Rhizopus and Mucor: sporangiophore
14. Aspergillus and Penicillium closely resemble
conidiospores and conidia
PAGE 12 #PASAR #RN2028 Lord Help Us Pass MICROPARA 〒▽〒MicroPara Lec - Finals
S.Y. 2024 - 2025 | Level I Midyear Term
○
YEAST
Mould forms are saprophytic: loves to feed
on dead plants and animal remains. This is
also why fungi are big factors and contributors
to decomposition.
CHARACTERISTICS
●
Unicellular eukaryotic organisms (unlike the molds
are multicellular)
●
Appear smooth and mucoid on the media
●
Aerobic organisms, but growth is enhanced in
anaerobic conditions
●
Acquire energy from an organic compound by
oxidation
Examples of Blastomyces dermatitidis, Coccidioides immitis,
Histoplasma capsulatum, Paracoccidioides brasiliensis
At 25°C, the forms are mycelial, or they look like
molds
At 37°C, they look like yeasts
●
●
●
●
Yeast Cell
A single cell reproduces asexually. Yeasts
reproduce through budding
The third “new cell” produces a daughter cell. And
each cell has a nucleus, cytoplasm, reserve food
bodies, and a vacuole
○
The vacuole is one distinctive feature of the
yeast, along with the budding
YEAST-LIKE FUNGI
●
Partly resemble yeast cells
●
Also develop pseudohyphae resembling hyphal
filaments
●
Opportunistic Fungi
These are the different forms of fungi that we can
see, and the fungi that can cause diseases or
mycosis.
○
First, yeast cells. We have the parent yeast
cell; it buds to produce daughters. During
budding, it can produce pseudohyphae or a
germ tube.
○
There are also the mould forms, candida, and
hyphae or hypha.
○
Cryptococcus is somewhat unique because of
the presence of capsules.
DIMORPHIC FUNGI TAXONOMIC CLASSIFICATION
CHARACTERISTICS
●
Exist in both mycelial and yeast forms in varying
temperatures
●
37°C: yeast-like colonies
●
25°C: mould-like colonies (esp. in soil)
○
Yeast forms are pathogenic
●
Taxonomy is the classification that considers not
just morphology but also the function, genetic,
biochemical, and behavioral aspects of the
organisms. It has a much broader scope and
consideration in classifying organisms.
PAGE 13 #PASAR #RN2028 Lord Help Us Pass MICROPARA 〒▽〒MicroPara Lec - Finals
S.Y. 2024 - 2025 | Level I Midyear Term
1. ZYGOMYCETES
●
Lower fungi with non-septate
hyphae produce sporangiospores
(asexual spores).
●
The spores are inside the
sporangium, so they are called
sporangiospores.
2. ASCOMYCETES
●
Produce septate hyphae and
ascospores. (Sexual spores are
present inside the sac or ascus)
●
Inside the ascus, there are the
ascus spores
●
Ascus is singular, and asci is plural
3. BASIDIOMYCETES
●
Produce septate hyphae and basidiospores.
(Sexual spores are present in the basidium)
●
The basidium looks like long, goblet cells. And, at
the top are basidiospores.
●
The goblets are called the basidium. Basidiospores
are the name of the spores found on the basidium
●
Basidiospores: Basidium look like goblet cells
○
Basidiospores, on top of it, what connects the
basidiospores and basidium is the sterigmata
○
Sterigmata look like small feet or pods
connecting the spores to the basidium
2. ASEXUAL SPORES
●
Vegetative spores
○
Formed by budding (yeast cells)
○
Formation of septa in hyphal filament (moulds)
○
Folding and thickening of hyphal filaments
(resulting in thick-walled spores)
●
Aerial spores
○
Conidiospores
○
Microconidia
○
Macroconidia
○
Sporangiospores
●
Labels
○
Conidiospore
○
Phialides
○
Vesicle
○
Conidiophore
○
Septate hyphae
SIGNIFICANCE OF FUNGI
4. DEUTEROMYCETES or FUNGI IMPERFECTI
●
Produce septate hyphae and cannot be classified
into sexual or asexual because their sexual state is
unknown
●
Share common features with ascomycetes
●
Most medically important fungi belong to this group
FUNGAL REPRODUCTION
SEXUAL or ASEXUAL
●
Fungal reproduction, whether it may be sexual or
asexual reproduction, produces spores
●
The spores are easily dispersed. And, it is
considered the most infective stage in cases of
infectious fungi because these spores are very
resistant and can survive dry and adverse
conditions
1. SEXUAL SPORES
●
Zygospores: found between hyphae
●
Ascospores: found inside the ascus. If the ascus
bursts, then the ascospores will be released
ADVANTAGES OF FUNGI
●
Decomposition
○
For carbon cycle = plants grow
●
Fermentation
●
Food
●
Pharmaceuticals
○
Fungal metabolites are used in antibiotic drugs
like penicillin = came from penicillium spp.
●
Model research organisms
○
Fungi are the basis of genetic research
because of their simple eukaryotic form. Before
they proceed to the multi-celled,
complicated-complex forms like humans, they
start with the simpler ones, like fungi and
bacteria
DISADVANTAGES OF FUNGI
●
Tree diseases
●
Crop diseases
●
Food spoilage
○
Bread molds, food molds, expiration date
molding
●
Wood and timber degradation
●
Mycoses or Fungal Infections
PAGE 14 #PASAR #RN2028 Lord Help Us Pass MICROPARA 〒▽〒MicroPara Lec - Finals
S.Y. 2024 - 2025 | Level I Midyear Term
MYCOSES
●
●
They are fungal infections. Term used to describe
fungal infections
Diseases caused by fungi
CAUSES OF MYCOSES TO HUMANS
1. INHALATION OF SPORES: enter the lungs, get
localized, cause respiratory infection
2. INOCULATION OF SPORES: through cuts, localize in
skin
3. ALTERATION OF NORMAL FLORA: due to
overconsumption of heavy dose of antibiotics (alter or
kills normal flora that acts as a physical barrier, this
enhancing entry of pathogenic fungi)
4. SUPPRESSED IMMUNE SYSTEM: patients undergoing
chemotherapy, in steroids due to transplantation, HIV, or
diabetics
4 SUBTYPES
1. Superficial Mycosis
2. Subcutaneous Mycosis
3. Deep Mycosis
4. Opportunistic Mycosis
SUPERFICIAL MYCOSIS
PATHOGENESIS
1. TRANSMISSION
●
Transmitted through contact, through adherence &
invasion of fungi
●
Become pathogenic when they change morphology
from yeast to mycelium (mold colony)
●
Dimorphic in nature
2. PIGMENTATION
●
Due to azelaic acid, which is the secondary
metabolite produce by fungi. It reacts on the
melanin pigments that is found on the skin. Thus,
producing pigments (patches)
3. SYMPTOMS
●
Mild patches on chest, back, neck, & arms
●
Patches lead to pigmentation
●
Discoloration starts spreading in untreated
conditions
●
Dryness of the skin
●
Itching of the skin
LABORATORY DIAGNOSIS
●
Specimen: skin scrapings of the lesions. Superficial
layers is enough
●
Direct microscopy: KOH (Potassium hydroxide)
wet mount. Skin scraping is fixed on slide with 20%
KOH, and then the skin scrapping is mixed into that
wet mount, covered with a cover slip. And then
short unbranched hyphae can be observed
Culture: Saubouraud’s Dextrose Agar, at 32-37
degrees celsius: round & smooth colonies
○
After the culture, it is then mounted on
lactophenol cotton blue wet mount to further
see the morphology of the malassezia species
●
●
Externally localize on the layers of skin, hair, & nail
& grow well on dead layers
Classified into two types:
○
Surface Mycoses
○
Cutaneous Mycoses
TINEA VERSICOLOR
●
Caused by Malassezia globosa
●
Is a yeast form of fungi that live on the skin in few
numbers but multiply during adverse conditions
leading to skin infections
●
They can exist as a normal flora, but during
adverse conditions, and with the several causes
mentioned earlier, it can lead to skin infection
●
TREATMENT
●
Topical application of antifungal ointments. Since it
is a superficial mycoses, ointments will do
○
Whitefield’s ointment: composed of benzoic
acid, salicylic acid, ciclopirox olamine, and
tincture of iodine
○
Sulfur-containing ointment
○
Oral antifungals: triazole, itraconazole,
ketoconazole. This is used in severe cases. If
the name ends with “azole”, it is most likely an
antifungal drug
TINEA NIGRA
●
Caused by Hortaea werneckii
●
Dimorphic fungi that exist in both yeast and hyphal
forms
●
Responsible for asymptomatic mycoses
PAGE 15 #PASAR #RN2028 Lord Help Us Pass MICROPARA 〒▽〒MicroPara Lec - Finals
S.Y. 2024 - 2025 | Level I Midyear Term
●
Saprophytic in nature & found on dead & decayed
materials
PATHOGENESIS
1. ENTRY
●
Inoculation of fungus through cuts and wounds.
●
Enter, localize, and cause superficial infection on
palms and foot soles.
●
From the name itself, you can deduce that the color
is darker, compared to Tinea versicolor.
2. HALOTOLERANT
●
It is tolerant to ionic stress, or the ability of
tolerance is the ability of an organism to grow
at salt concentrations higher than those for
growth.
●
Able to survive in human tissues by
accumulating and utilizing melanin. It can survive
on areas of the skin that actually are more
prone to sweat, like the palms and foot soles.
●
Because of its appearance, there are times that
this mycoses is confused with the type of skin
cancer or melanoma.
3. SYMPTOMS
●
Mild patches on palms and foot soles.
●
Patches appear brownish or black in color.
Irregular in shape.
●
Scale-like skin growth
●
Itching
●
If asymptomatic, you cannot
see any of these symptoms. But
there is fungal present still on the skin.
LABORATORY DIAGNOSIS
●
Specimen: Skin scrapings of the lesions.
Because it is superficial.
●
Direct Microscopy: KOH wet mount. Budding
yeast cells on branched hyphal elements.
●
Culture: SDA, at 32 ̊C - 37 ̊C, 3 weeks:
dematiaceous colonies that become velvety with
age. In culture, they appear mycelial bold-like
forms, unlike the Malassezia that appears
yeast-like. Very slow forming fungal colony.
Even in 3 weeks, it is still small in size (coin- sized).
●
Lactophenol Cotton Blue: Further testing of
isolated colonies.
○
This is the wet
mount using LPCB
because it is blue
and it can be seen
more clearly,
compared to the
○
previous slide which contains KOH wet
mount. These fungal colonies are that much
clearer. You can see the form is fully
mycelial. You can see the hyphae. Previous
slide was not that clear because there is a
mixture of yeast cells and mycelial hyphal
elements – like in the middle of transformation.
Since the LPCB gets its specimen from the
colony grown in culture, you can see the
form is now fully mycelial or hyphal.
TREATMENT
●
●
●
Topical application of antifungal ointments.
Good hygiene
Avoiding exposure to moist and dirty places.
PIEDRA
●
●
This affects the hair
Two types:
○
White Piedra
○
Black Piedra
1. WHITE PIEDRA
●
Caused by
Trichosporon beigelii.
●
Asexuallyreproductive
●
Part of normal flora
●
Yeast-like fungi that
change to septate
hyphal filaments.
●
Dimorphic
●
Pathogenesis:
○
Close contact with the infected person’s towel,
soap, comb, etc.
○
White nodules: spores transmitted by contact
●
Symptoms:
○
Acclimation of white lump of yeast cells on the
hair follicles of the head, beard, even pubic
hair. You can directly get this & place it on the
wet mount & immediately see the yeast cells
○
Hair loss
○
Itching
2. BLACK PIEDRA
●
Caused by the fungi, Piedraia hortae.
●
Asexual
●
Transmitted through contact.
●
Pathogenesis:
○
Found on hair shafts of the beard and scalp.
PAGE 16 #PASAR #RN2028 Lord Help Us Pass MICROPARA 〒▽〒MicroPara Lec - Finals
S.Y. 2024 - 2025 | Level I Midyear Term
●
Symptoms:
○
Brown to black nodules firmly attached to the
hair shaft.
○
Nodules: ascostroma (asci and ascospores).
○
Mostly asymptomatic
○
Hair breakage in extreme cases
LABORATORY DIAGNOSIS
●
Specimen: Hair
●
Direct Microscopy: KOH wet mount Hair nodules
●
Culture: Sabouraud Dextrose Agar
●
LPCB: Further testing of isolated colonies can be
done through LPCB
TREATMENT
●
●
Topical application of antifungal ointments
○
Imidazoles & selenium sulfide
○
Amphotericin B ointments
Using separate towels, soaps, & combs
SUBCUTANEOUS MYCOSIS
●
●
Causes disease in living tissues leading to tissue
damage
Three types
○
Mycetoma
○
Chromoblastomycosis
○
Rhinosporidiosis
MYCETOMA
●
Persistent subcutaneous granulomatous infection
affecting the foot, & as infection progresses, the
bones.
●
Aka: Madura foot
●
Caused by Actinomycetes (Actinomycetoma) or
Filamentous fungi (Eumycetoma)
○
Aerobic, filamentous fungi commonly found in
soil
○
Mycetoma is not just caused by fungi, by
bacteria such as the Actinomycetes
PATHOGENESIS
1. TRANSMISSION
●
Inoculation of fungus through cuts or wounds from
soil
●
Enter tissue, localize, & replicate inside live cells
●
Spores from clumps inside cells resulting in
granules
○
Granules vary in color, depending on
contributing agents
2. SYMPTOMS
●
Itching
●
Swelling in area of itching
●
Pus formation
●
Ulceration & nodules
●
Pus expulsion
●
Irrigation in area of infection (watery irrigation)
●
Disfiguration of leg
LABORATORY DIAGNOSIS
●
Specimen: Pus exudates
●
Direct microscopy:
○
Gram staining: for identification of
actinomycetes (gram positive)
○
KOH Wet mount: for identification of
Eumycetes (fungi)
●
Culture: after the direct microscopy, if it is found to
be a bacteria, the it can be grown on Blood Agar or
Nutrient Agar. If it is found to be a fungi, then it is
grown on Sauboraud’s Dextrose Agar (SDA)
TREATMENT
●
Surgery & removal of abscess at early stage with
proper administration of oral antifungal &
antibacterial drug therapy (to prevent the further
spread of the fungi
○
Actinomycetoma: Antibacterial drug;
Rifampicin, Dapsone, & Sulphonamides
○
Eumycetoma: Oral antifungal; Itraconazole &
Ketoconazole
●
Treatment should be prolonged for complete
eradication of pathogens. Because in mycetoma, it
affects the deeper tissues, which is why treatment
needs to be completely eradicated as it can spread
if treatment is not enough.
CHROMOBLASTOMYCOSIS
●
Caused by five different vegetative fungi
(pathogens)
○
Phialophora verrucosa
○
Fonsecaea compacta
○
Fonsecaea pedrosoi
PAGE 17 #PASAR #RN2028 Lord Help Us Pass MICROPARA 〒▽〒MicroPara Lec - Finals
S.Y. 2024 - 2025 | Level I Midyear Term
●
●
●
○
Rhinocladiella aquaspersa
○
Cladophialophora carrionii
Cause persistent infection that slowly progress &
form granulomatous lesions
○
Lead to accumulation of keratinocytes in
epidermal layer resulting in sloughing of skin
Caused by Actinomycetes (Actinomycetoma) or
Filamentous fungi (Eumycetoma)
○
Aerobic, filamentous fungi commonly found in
soil
Mycetoma is not just caused by fungi, by bacteria
such as the Actinomycetes
PATHOGENESIS
●
Chronic subcutaneous infection
●
Transmission: cuts or wounds, primarily in leg
region
○
Upon entry, fungi spreads and invades tissue
very slowly (due to slow growing capacity)
○
Very resistant to immune cells due to its
melanin cell wall
●
Affects tissue:
○
Forming hyperplasia of epidermis producing
nodules with pus formation
○
Distinct feature: painless
●
Drains lymphatics:
○
Severe: damage organs
○
It can take years undetected. It starts with
nodules, if not treated, then it can drain the
lymphatics, & cause organ damage
●
Symptoms:
○
Itching in area of entry
○
Swelling with pus formation
○
Nodule formation as infecting drains to lymph
○
Ulcerations
LABORATORY DIAGNOSIS
●
Specimen: pus cells or skin scrapings
●
Methods:
○
KOH wet mount
○
Histopathological analysis: check
multinucleated giant cells with granules &
sclerotic bodies inside the outside cells
○
Culture: SDA, brown, or black moldy colonies
TREATMENTS
●
Surgery & removal of pustule & proper oral
treatment
●
Heat therapy (early stages)
●
Antifungal agents
○
Flucytosine
○
○
Ketoconazole
Itraconazole
RHINOSPORIDIOSIS
●
Granulomatous infection of the nose, eyes, & mouth
●
Caused by Rhinosporidium seeberi
●
First classified as sporozoan parasite, but later
classified as lower fungi
●
Still shares morphological similarities with aquatic
parasites
●
According to DNA sequencing, belongs to fish
parasite (which is right between animal and fungal
division)
PATHOGENESIS
●
Fishermen & washermen are mostly affected due to
constant contact with water habitats
●
Mode of transport: entry thru cuts & wounds
○
Also enters through nasopharyngeal route or
even eyes & external genitals
●
Symptoms:
○
Accumulation of large mass of cells that hangs
out as a separate layer
○
Pus accumulation leading to foul smell
○
Breathing difficulty due to protrusion of layer
●
Lab diagnosis:
○
Skin biopsy: Histopathological analysis
○
KOH wet mount: for endospores within
sporangium
●
Treatment:
○
Surgery
○
Intravenous administration & amphotericin B
and Dapsone
DEEP MYCOSIS
●
●
Otherwise called systemic mycosis
Involves both pathogenic and opportunistic fungi
yeast form and start invading tissue
○
Pathogenic Fungi: Gain entry
○
Opportunistic Fungi: Suppress the immune
system
PAGE 18 #PASAR #RN2028 Lord Help Us Pass MICROPARA 〒▽〒MicroPara Lec - Finals
S.Y. 2024 - 2025 | Level I Midyear Term
HISTOPLASMOSIS
●
Systemic mycosis caused by Histoplasma
capsulatum
○
Saprophytic fungi mostly found in soil glands
○
Dimorphic fungus
○
Solo-celled microconidia
●
Colony Culture:
○
Produces moldy white colonies
●
Affects respiratory system causing pulmonary
infection
○
○
○
○
Does not involve the fungi itself
Involves antibody-antigen reaction
Reacts to blood antigen
One of the fastest tests due to fungal colonies
needing to take a few days for culture to
develop
TREATMENT
●
Itraconazole
●
Amphotericin B
●
Relapses may occur for immunocompromised
patients (prolonged treatment with itraconazole
PATHOGENESIS
●
Intracellular pathogen
●
Mode of transmission: Inhalation; Molds convert
to
●
Yeast cells engulfed by alveolar macrophages
●
Yeast replicates inside & use the host cells to travel
around the body & invade other areas like liver,
spleen, & lymph nodes
●
Results in pulmonary infection in men, children &
immunocompromised patients (aids & undergoing
chemotherapy
●
Symptoms:
○
Dry cough
○
Body pain
○
High fever
○
Restlessness
○
Lymphadenopathy
○
Fatal in severe cases affecting liver, eyes, &
glands
LAB DIAGNOSIS
●
Specimen: sputum, urine, throat swab, bone
marrow aspirator
●
Direct microscopy: histopathological staining or
Giemsa staining to view intracellular yeast (biopsy
specimen)
○
KOH will not work
●
Culture: SDA (for moldy colonies), blood agar (for
yeast colonies)
●
Serology: complement fixation test & enzyme
immunoassay
OPPORTUNISTIC MYCOSIS
●
Infection that occur in immunocompromised
●
patients
Depends on the load of organism and the
virulence caused to the host
1. CANDIDIASIS
●
Caused by Candida albicans, Candida tropicalis,
Candida parapsilosis and Candida krusei
●
Part of normal flora of skin and GIT
●
Cells are oval-shaped and divide by budding, which
form into pseudohyphae
●
Some species like C. albicans are dimorphic
2. CRYPTOCOCCOSIS
●
Caused by Cryptococcus neoformans and
Cryptococcus gattii
●
Mostly found in soil, feces of birds
●
Yeast-like fungi with resistant polysaccharide
capsules
●
Can be cultured using fungal or bacteriological
media, 24 hrs at 37 degrees C
●
Colony: produces mucoid white colonies (due to
capsule)
PAGE 19 #PASAR #RN2028 Lord Help Us Pass MICROPARA 〒▽〒MicroPara Lec - Finals
S.Y. 2024 - 2025 | Level I Midyear Term
PATHOGENESIS
●
Mode of transmission: inhalatioN of fungal cells
●
Enter respiratory system, affecting circulating
cells and compromises immune system by
resisting immune reactions
●
Multiply and infect other parts of the body,
especially the CNS causing meningoencephalitis
(inflammation of brain tissues and meninges)
●
Symptoms:
○
Fever
○
Headache
○
Body pain
○
Flu symptoms
○
CNS affected in severe causes, causing
encephalitis
LAB DIAGNOSIS
●
Specimen collected: Sputum, Blood (severe
systemic cases), Throat swab, CSF (suspected
encephalitis)
●
Direct microscopy
○
India Ink: special staining used specifically for
showing the capsule of Cryptococcus spp.
●
Serology
TREATMENT
●
Amphotericin B and flucytosine
○
Combination of both for severe cases (ie:
immunocompromised patients)
○
Prolonged treatment provided to avoid
recurrent infections
me and bestie looking at micropara scores
PAGE 20 #PASAR #RN2028 Lord Help Us Pass MICROPARA 〒▽〒MicroPara Lec - Finals
S.Y. 2024 - 2025 | Level I Midyear Term
27 VIROLOGY
study of viruses and virus-like agents
VIRUSES
●
●
●
●
●
●
●
●
●
●
●
Simplest form of life and smallest known
infectious agents
Submicroscopic, Intracellular obligate parasites
Filterable agents
Have a naked capsid or an envelope morphology
Capable of infecting any animal, plant, or
bacterial cell
○
Since they are the smallest, they can infect
anything, including bacteria
Viral components are assembled and do not
replicate by “division”
Are not living organisms
Must be infectious to endure in nature
Must be able to use host cell processes to
produce their components (viral messenger
RNA, protein, and identical copies of the genome).
Must encode any required processes not
provided by the cell
Viral components must self-assemble
RELATIVE SIZES OF REPRESENTATIVE VIRUSES,
BACTERIOPHAGES, & BACTERIA
●
Smallest
virus:
parvovirus,
picornavirus
VIRUSES: CLASSIFICATION & NAMING
VIRUSES: STRUCTURE
1. STRUCTURE: size, morphology, and nucleic acid
2. BIOCHEMICAL CHARACTERISTICS: structure and
mode of replication
●
so far this is the main means of taxonomic
classification of a virus
3. DISEASE: e.g., Hepatitis, encephalitis
4. MEANS OF TRANSMISSION: ex. Arbovirus (spread
by insects)
5. HOST CELL (HOST RANGE): animal (human, mouse,
bird), plant, bacteria
6. TISSUE OR ORGAN (TROPISM): ex. Adenovirus,
enterovirus
●
Adeno: affects respiratory tract; entero affects
GIT)
COMPONENTS OF THE BASIC VIRION
Main properties that differentiate them from other
microorganisms
1. SMALL SIZE
●
Varies from 10 to 300 nm (some can even
extend to 2000 nm depending on which virus it
is)
●
Cannot be observed under the light microscope
(due to its minute size, bacteria is in micrometers,
this is in nano)
●
Can be measured through membrane filters,
ultracentrifugation, and electron microscopy
2. GENOME
●
viruses carry their own genetic material (DNA or
RNA; neverboth)
●
genome may be single stranded or double
stranded, circular or linear, segmented or
unsegmented
3. METABOLICALLY INERT
●
no metabolic activity outside their hosts
●
do not possess machinery for translation and
can only multiply inside living cells
●
●
Nucleocapsid is composed of (not all
necessarily present)
○
DNA or RNA (genome)
○
Structural proteins
○
With or without enzymes
○
Nucleic acid binding proteins
Nucleocapsid enclosed in naked capsid virus
PAGE 21 #PASAR #RN2028 Lord Help Us Pass MICROPARA 〒▽〒MicroPara Lec - Finals
S.Y. 2024 - 2025 | Level I Midyear Term
●
●
●
Nucleocapsid and glycoproteins and membrane
makes up the enveloped virus
Nucleocapsid + glycoproteins and membrane =
the enveloped virus
The pink one is a naked capsid virus, the one
below is the envelope virus
VIRUSES: RNA VIRUSES
VIRUSES: STRUCTURE (2)
●
●
●
CAPSID: Rigid structure able to withstand harsh
environmental conditions
ENVELOPE: Membrane composed of lipids,
proteins, and glycoproteins
○
Membranous structure can be maintained
only in aqueous solutions
○
Easily disrupted by drying, acidic condition,
detergents and solvents which results in
inactivation of the virus
As a result, envelope viruses must remain wet and
are generally transmitted in fluids, respiratory droplets,
blood and tissue. Most of them cannot survive the
harsh conditions of the GIT tract
FUNCTIONS OF CAPSID
●
Protects the viral genome from physical
destruction and enzymatic inactivation
●
Serves as vehicle of transmission from one
host to another
●
Facilitates assembly and package of viral
genetic information
●
Antigenic and specific for each virus type
●
Provides structural symmetry to the virus particle
9 jd sha originally but sir added 6 para good to know lng daw
(ang other viruses naa sa pic below)
1. CORONAVIRIDAE: Coronaviruses (i.e., SARS-CoV-
2, MERS-CoV)
2. FILOVIRIDAE: Ebola and Marburg hemorrhagic fever
viruses
3. FLAVIVIRIDAE: Arboviruses (i.e., Dengue, yellow
fever, West Nile, Japanese encephalitis), non
arboviruses (i.e., hepatitis C virus)
4. ORTHOMYXOVIRIDAE: Influenza A, B, and C viruses
5. PARAMYXOVIRIDAE: Parainfluenza viruses, mumps
virus, measles virus
6. PICORNAVIRIDAE: Polio viruses, hepatitis A virus,
rhinovirus
7. RETROVIRIDAE: HIV types 1 and 2, HTLV types 1
and 2
8. RHABDOVIRIDAE: Rabies virus
9. TOGAVIRIDAE: Rubella virus
SUMMARY KINEME GI DRAW NI SIR SA BOARD
VIRUSES: DNA VIRUSES
1. ADENOVIRIDAE: human adenoviruses
2. HEPADNAVIRIDAE: Hepatitis B virus
3. HERPESVIRIDAE: HSV types I and II,
Varicella-Zoster Virus (VZV), Cytomegalovirus (CMV),
Epstein–Barr virus (EBV), human herpesviruses 6 & 7
(associated with roseola), and 8 (Kaposi Sarcoma
Cancer)
4. PAPILLOMAVIRIDAE: Human papilloma viruses
(Cervical & penile cancer)
5. PARVOVIRIDAE: Parvovirus B-19 (CNS, erythema
infectiosum)
6. POXVIRIDAE: Variola, vaccinia, orf, molluscum,
contagiosum, monkeypox viruses, smallpox
VIRUSES: DNA VIRUSES
DNA VIRUSES:
ADENOVIRUSES
FAMILY ADENOVIRIDAE (Adenovirus)
Virus Adenovirus
PAGE 22 #PASAR #RN2028 Lord Help Us Pass MICROPARA 〒▽〒MicroPara Lec - Finals
S.Y. 2024 - 2025 | Level I Midyear Term
Characteristics
●
●
●
●
dsDNA genome
Icosahedral capsid
No envelope
~50 human serotypes
●
Transmission
Respiratory, fecal-oral, and direct contact
(eye)
Site of Latency
(virus enter latent
period, latent period
= virus is able to
exist in the body
undetected by the
immune system;
they only replicate
from external factor
like stress)
Replication in oropharynx
○
○
○
○
○
with delta virus (1%);
Hep D won’t be attached to liver
without Hep B (precursor)
Chronic hepatitis
persistence of hepatitis B surface
antigen (HBsAg) (9%) followed by
resolution (disappearance of
HBsAg),
Asymptomatic carrier state,
Chronic persistent (systemic
disease without progressive liver
disease), or
chronic active disease
(progressive liver damage);
Oncogenic: Liver cancer
Treatment Antivirals and liver transplant for fulminant
disease
Disease
●
●
●
●
●
●
●
pharyngitis,
pharyngoconjunctival fever
keratoconjunctivitis
pneumonia
hemorrhagic cystitis
disseminated disease
gastroenteritis in children
Prevention HBC vaccine; hepatitis B immune globulin
DNA VIRUSES:
HERPESVIRUSES
Treatment Supportive
FAMILY HERPESVIRIDAE (Herpesvirus - HSV)
Prevention
Vaccine (adenovirus serotypes 4 & 7) for
military recruits
Virus HSV-1 and HSV-2
DNA VIRUSES:
HEPADNAVIRUSES
●
●
●
FAMILY HEPADNAVIRIDAE (Hepadnavirus)
Characteristics
Virus Hepatitis B Virus
Characteristics
●
●
●
●
partly dsDNA genome
icosahedral capsid with envelope
virion (also called Dane particle)
surface antigen originally termed
Australia antigen
○
○
○
○
○
○
○
○
Double-stranded deoxyribonucleic acid
(DNA) genome;
icosahedral capsid with envelope;
at least eight human herpes viruses
known:
HSV-1
HSV-2
Varicella-Zoster virus (VZV)
Epstein-Barr virus (EBV)
Cytomegalovirus (CMV)
Human herpesvirus (HHV)-6
HHV-7
HHV-8
Transmission Direct contact with infected secretions
Transmission
Humans are reservoir and vector; spread
by direct contact, including exchange of
body secretions, recipient of contaminated
blood products, percutaneous injection of
virus, and perinatal exposure
Site of Latency Sensory nerve ganglia
●
Site of Latency Liver
Disease
Disease
●
●
Acute infection with resolution (90%)
Resolves on its own, but if not then:
Fulminant hepatitis, most coinfected
○
○
○
○
○
○
○
Predominant virus in parentheses
Gingivostomatitis (HSV-1),
Pharyngitis (HSV-1),
Herpes labialis (HSV-1)
Genital infection (HSV-2)
Conjunctivitis (HSV-1)
Keratitis (HSV-1)
Herpetic whitlow (HSV-1 and
PAGE 23 #PASAR #RN2028 Lord Help Us Pass MICROPARA 〒▽〒MicroPara Lec - Finals
S.Y. 2024 - 2025 | Level I Midyear Term
○
○
HSV-2)
Encephalitis (HSC-1 in adults)
Disseminated disease (HSV-1 or
HSV-2 in neonates)
Disease
Asymptomatic infection, congenital disease
of newborn, symptomatic disease of
immunocompromised host,
heterophile-negative infectious
mononucleosis
Treatment Acyclovir, valacyclovir, famciclovir
Treatment Prevention Avoid contact.
Supportive; decrease immune suppression;
ganciclovir and foscarnet
FAMILY HERPESVIRIDAE (Herpesvirus - HSV)
Prevention
Use CMV antibody-negative blood and
tissue for transfusion and transplantation,
respectively.
Virus VZV (Varicella Zoster Virus)
Transmission
Close personal contact, especially
respiratory
FAMILY HERPESVIRIDAE (Herpesvirus - HSV)
Virus HHV-6 and HHV-7
Site of Latency Dorsal Root Ganglia
Disease Chickenpox (varicella), shingles (zoster)
Transmission
Most likely close contact via respiratory
route; almost all children infected age 2-3
years
Treatment Acyclovir, famciclovir
Site of Latency T lymphocytes (CD4 cells)
Prevention Vaccine
Disease
Roseola (exanthem subitum), fever,
malaise, rash, leukopenia, and interstitial
pneumonitis in organ transplant recipients
FAMILY HERPESVIRIDAE (Herpesvirus - HSV)
Treatment Susceptible to ganciclovir and foscarnet
Virus EBV (Epstein Barr Virus)
Transmission Close contact with infected saliva
Prevention None practical
Site of Latency B Lymphocytes
FAMILY HERPESVIRIDAE (Herpesvirus - HSV)
Disease
Infectious mononucleosis, progressive
lymphoreticular disease, oral hairy
leukoplakia in patients with HIV
Oncogenic: Burkitt lymphoma,
nasopharyngeal carcinoma
Virus HHV-8
Transmission
Not known; much less widely disseminated
than other herpes viruses
Treatment Supportive
Site of Latency
Prevention Avoid contact
Viral genome found in Kaposi tumor cells,
endothelial cells, and tumor-infiltrating
leukocytes
Disease Kaposi sarcoma (Type of Cancer)
FAMILY HERPESVIRIDAE (Herpesvirus - HSV)
Treatment None known
Virus CMV (Epstein Barr Virus)
Prevention Avoid contact with virus
Transmission
Close contact with infected secretions, blood
transfusions (WBCs), organ transplants,
transplacental
Site of Latency
WBCs, endothelial cells, cells in a variety of
organs
PAGE 24 #PASAR #RN2028 Lord Help Us Pass MICROPARA 〒▽〒MicroPara Lec - Finals
S.Y. 2024 - 2025 | Level I Midyear Term
DNA VIRUSES:
PAPILLOMAVIRUSES
DNA VIRUSES:
POXVIRUSES
FAMILY PAPOVAVIRIDAE (Papillomavirus)
FAMILY POXVIRIDAE (Poxvirus)
Virus Human papillomavirus (HPV)
Virus
Smallpox, molluscum contagiosum, orf, and
monkeypox viruses
Characteristics
●
dsDNA genome, icosahedral capsid,
no envelope, contains >200 DNA types
Transmission
Direct contact or sexual contact for genital
warts
Characteristics
Largest and most complex of all viruses;
brick-shaped virion with nonconforming
symmetry, referred to as complex; dsDNA
genome
Site of Latency Epithelial tissue
Transmission
Disease
Skin and genital warts, benign head and
neck tumors, anogenital warts
Oncogenic: Cervical and penile cancer
(esp. HPV types 16 and 18)
Respiratory droplets (smallpox); direct
contact (molluscum contagiosum, orf,
monkeypox)
Disease
Treatment Surgical or chemical removal may be
necessary
Erythema infectiosum (fifth disease),
aplastic crises in patients with chronic
hemolytic anemias, and fetal infection and
stillbirth
Prevention
Avoid contact with infected tissue,
vaccination
Treatment Supportive
Prevention
Vaccine for smallpox; avoid contact for all
viruses.
DNA VIRUSES:
PARVOVIRUSES
VIRUSES: RNA VIRUSES
FAMILY PARVOVIRIDAE (Parvovirus)
Virus Parvovirus B-19
RNA VIRUSES: CORONAVIRUSES
Characteristics
ssDNA genome, icosahedral capsid, no
envelope; parvovirus B-19 is the only
known human parvovirus
FAMILY CORONAVIRIDAE (Coronaviruses)
Transmission Close contact, probably respiratory
Virus Coronavirus
Site of Latency Central nervous system
Disease
Erythema infectiosum (fifth disease),
aplastic crises in patients with chronic
hemolytic anemias, and fetal infection and
stillbirth
Characteristics
●
●
●
80-160 nm
ssRNA genome
helical capsid with envelope
Transmission Direct contact or aerosol
Treatment Supportive
Target Receptor
Prevention Avoid contact
ACE2 (Angiotensin Converting Enzyme 2) -
found in: heart, kidney, testis, nasal and oral
mucosa, nasopharynx, bone marrow, spleen,
brain, lung, small intestine
Disease
●
●
Common cold
possibly gastroenteritis, especially in
PAGE 25 #PASAR #RN2028 Lord Help Us Pass MICROPARA 〒▽〒MicroPara Lec - Finals
S.Y. 2024 - 2025 | Level I Midyear Term
●
●
children
SARS
COVID-19
an envelope
Transmission Arthropod vector, usually mosquito
Treatment Supportive
Target Receptor
●
●
●
GAG (glycosaminoglycans)
GSL (glycosphingolipid)
Lectins
Prevention
●
●
Vaccine (SARS-CoV-2)
Avoid contact with virus
Disease
●
●
St. Louis and West Nile encephalitis
dengue and yellow fever
RNA VIRUSES: FILOVIRUSES
Treatment Supportive
FAMILY FILOVIRIDAE (Filovirus)
Prevention
●
●
●
Avoid contact with vector
vector control programs
Vaccine (DENV)
Virus Ebola (or Ebola-Reston) and Marburg viruses
Characteristics
●
●
●
80-14,000 nm
enveloped, long
filamentous and irregular capsid forms
with ssRNA
FAMILY FLAVIVIRIDAE (Flavivirus)
Virus Hepatitis C virus (HCV)
Transmission
●
●
Transmissible to humans from
monkeys and, presumably, other wild
animals
human-to-human transmission via body
fluids and respiratory droplets
Transmission Parenteral or Sexual
Target Receptor
●
●
GAG (glycosaminoglycans)
LDLR (low-density lipoprotein receptor)
●
●
Target Receptor
TIM-1 (T-cell immunoglobulin and mucin
domain 1) - found in: mast cells, NKT cells, B
cells
Disease
Acute and chronic hepatitis
strong correlation between chronic
HCV infection and hepatocellular
carcinoma
Disease
Severe hemorrhage and liver necrosis;
mortality as high as 90%
Treatment Supportive, interferon
Treatment Supportive
Prevention
●
●
Avoid contact with virus
blood supply screened for antibody for
the hepatitis C virus
Prevention
●
●
Avoid contact with virus
Export prohibitions on wild monkeys
RNA VIRUSES:
ORTHOMYXOVIRUSES
RNA VIRUSES: FLAVIVIRUSES
FAMILY ORTHOMYXOVIRIDAE (Orthomyxovirus)
Virus Influenza A
FAMILY FLAVIVIRIDAE (Flavivirus)
Virus
Arboviruses,
* including yellow fever, dengue,
West Nile, Japanese encephalitis and St.
Louis encephalitis viruses
Characteristics
●
●
●
80-200 nm, segmented (eight separate
molecules) ssRNA genome
helical capsid with envelope.
Three major antigenic types; influenza
A, B, and C; types A and B cause
nearly all human disease
Characteristics
●
●
40-50 nm
ssRNA genome surrounded by
spherical and icosahedral capsid with
Transmission Contact with respiratory secretions
PAGE 26 #PASAR #RN2028 Lord Help Us Pass MICROPARA 〒▽〒MicroPara Lec - Finals
S.Y. 2024 - 2025 | Level I Midyear Term
Target Receptor Airway epithelial cells
Transmission
Contact with respiratory secretions; extremely
contagious
Disease
●
●
●
Influenza (fever, malaise, headache,
myalgia, cough)
primary influenza pneumonia
In children: bronchiolitis, croup, otitis
media
Target Receptor Airway epithelial cells
Disease
Measles, atypical measles (occurs in those
with waning vaccine immunity), and subacute
sclerosing panencephalitis
Treatment
Supportive; antivirals amantadine and
rimantadine (A only), and zanamivir and
oseltamivir (A and B)
Treatment Supportive; immunocompromised patients
can be treated with immune serum globulin
Prevention Influenza vaccine or antiviral prophylaxis
Prevention Measles vaccine
FAMILY ORTHOMYXOVIRIDAE (Orthomyxovirus)
FAMILY PARAMYXOVIRIDAE (Paramyxovirus)
Virus Influenza B
Virus Mumps virus
Transmission Contact with respiratory secretions
Transmission
Person-to-person contact; presumably
respiratory droplets
Disease Similar to “mild” influenza
Disease Mumps
Treatment Supportive; antivirals zanamivir and
oseltamivir
Treatment Supportive
Prevention Influenza vaccine or antiviral prophylaxis
Prevention Mumps vaccine
FAMILY ORTHOMYXOVIRIDAE (Orthomyxovirus)
FAMILY PARAMYXOVIRIDAE (Paramyxovirus)
Virus Influenza C
Virus Parainfluenza virus
Transmission Contact with respiratory secretions
Transmission Contact with respiratory secretions
Disease Mild form of influenza causing URTIs
Disease
Treatment Supportive
●
●
Adults: upper respiratory disease; rarely
pneumonia
Children: respiratory, including croup,
bronchiolitis, and pneumonia
Prevention Avoid contact with virus
Treatment Supportive
Prevention Avoid contact with virus
RNA VIRUSES:
PARAMYXOVIRUSES
FAMILY PARAMYXOVIRIDAE (Paramyxovirus)
RNA VIRUSES:
PICORNAVIRUSES
Virus Measles virus
FAMILY PICORNAVIRIDAE (Picornavirus)
Characteristics
●
●
●
●
150-300 nm
ssRNA genome
helical capsid with envelope
no segmented genome
Virus
Poliovirus (3 types); Coxsackie virus, group A
(23 types); Coxsackie virus, group B (6
types); Echovirus (31 types); Enteroviruses (5
types)
PAGE 27 #PASAR #RN2028 Lord Help Us Pass MICROPARA 〒▽〒MicroPara Lec - Finals
S.Y. 2024 - 2025 | Level I Midyear Term
Characteristics
●
●
28-30 nm, ssRNA genome
icosahedral capsid with no envelope
Characteristics
Transmission Fecal-oral
●
●
100-120 nm, ssRNA genome,
icosahedral capsid with envelope
Reverse transcriptase converts
genomic RNA into deoxyribonucleic
acid (DNA)
Disease
Polio (poliovirus); herpangina (coxsackie A);
pleurodynia (coxsackie B); aseptic meningitis
(many enterovirus types); handfoot-mouth
disease (coxsackie A); pericarditis and
myocarditis (coxsackie B); acute hemorrhagic
conjunctivitis (enterovirus 70); and fever,
myalgia, summer "flu" (many enterovirus
types), neonatal disease (echoviruses and
coxsackie viruses)
Transmission
Sexual contact, blood and blood product
exposure, and perineal exposure
Disease
Treatment Supportive; pleconaril in development
Most disease in humans cause by HIV-1;
infected cells include CD 41 (helper) T
lymphocytes, monocytes, and some cells of
the CNS; asymptomatic infection, acute flulike
disease, acquired immunodeficiency
syndrome (AIDS)-related complex, and
AIDS-associated infections and malignancies
Prevention Avoid contact with virus; vaccine (polio)
Treatment
FAMILY PICORNAVIRIDAE (Picornavirus)
Nucleoside reverse transcriptase inhibitors,
nonnucleoside reverse transcriptase
inhibitors, protease inhibitors, and inhibitors of
viral entry into host cells; treat infections
resulting from immunosuppression
Virus Hepatitis A virus (enterovirus type 72)
Target Receptor
Transmission Fecal-oral
CD4 recetor - T helper cells, monocytes,
macrophages and dendritic cells
Disease
Hepatitis with short incubation, abrupt onset,
and low mortality; no carrier state
FAMILY RETROVIRIDAE (Retrovirus)
Treatment Supportive
Virus
Human T-lymphotropic viruses types 1 and 2
(HTLV-1, HTVL-2)
Prevention
Vaccine; prevent clinical illness with serum
immunoglobulin
Transmission
Known means of transmission are similar to
those for HIV
FAMILY PICORNAVIRIDAE (Picornavirus)
Disease
Virus Rhinovirus (common cold virus)
T-cell leukomia and lymphoma, and tropical
spastic parapaersis for HTLV-1; T-cell
lymphoma (HTLV-1); no known disease
associations for HTVL-2
Characteristics Approx. 100 serotypes
Treatment Supportive
Transmission Contact with respiratory secretions.
Prevention Avoid contact with virus
Treatment Supportive
Prevention Avoid contact with virus
RNA VIRUSES: RHABDOVIRUSES
RNA VIRUSES: RETROVIRUSES
FAMILY RHABDOVIRUSES (Rhabdovirus)
Virus Rabies virus
FAMILY RETROVIRIDAE (Retrovirus)
Virus
Human immunodeficiency virus types 1 and 2
(HIV-1, HIV-2)
Characteristics
●
●
70-180nm, ssRNA genome
helical capsid with envelope,
bullet-shaped
PAGE 28 #PASAR #RN2028 Lord Help Us Pass MICROPARA 〒▽〒MicroPara Lec - Finals
S.Y. 2024 - 2025 | Level I Midyear Term
Transmission
Bite of rabid animals most common; 20% of
human rabies cases have no known exposure
to rabid animal
Disease Rabies
Treatment Supportive
Target Receptor
nAChr (nicotinic acetylcholine receptor),
NCAM (cell adhesion molecule, p75NTR (p75
neurotrophin receptor - Nerve cells
Prevention
Avoid contact with rabid animals; vaccinate
domestic animals; post-exposure prophylaxis
with hyperimmune antirabies globulin and
immunization with rabies vaccine
RNA VIRUSES: TOGAVIRUSES
●
●
Symptoms: malaise, headache, fever,
hypertonic muscles, anxiety with episode of
hyperactivity, aggression, and convulsions,
hydrophobia (patient attempts to drink but this
brings painful spasms in larynx and pharynx
which leads to choking and gagging) along with
intense thirst
Treatment and Prophylaxis: First-aid, Human
rabies immunoglobulin is administered
intramuscularly, rabies vaccine, tetanus
prophylaxis
Loves nerve cells (CNS). It travels along the nerve,
not coming into contact with the immune system. It is
only after the virus spreads from the CNS, along the
nerve trunks to the different parts of the body that
antibodies are produced. By this time, irreversible
damage to the CNS has taken place and patient dies
of respiratory paralysis.
FAMILY Togaviridae (Togavirus)
Virus Rubella Virus
Characteristics
●
●
●
60-70nm, ssRNA genome
icosahedral capsid with envelope
family contains arboviruses and
non-arthropod-borne rubella virus
Transmission Respiratory, transplacental
Disease
Rubella (mild exanthematous disease) and
congential rubella
Treatment Supportive
Target Receptor Respiratory epithelium of nasopharynx
Prevention Rubella vaccine
VIRAL INFECTIONS
VIRAL INFECTION: RABIES
●
Virus: Rabies virus (Rhabdoviridae)
●
Inactivation: Sensitive to alcohol and lipid
solvents (ether, chloroform, acetone). Can be
inactivated by phenol, formalin, UV light, and
heat. Virus remains stable for several days at
0-4 degrees C and indefinitely at -70 degrees C
●
Source: bite from infected animals
●
Incubation period: 1-2 months
●
Affected cells/ system: CNS
VIRAL INFECTION AIDS
●
Virus: HIV (Retroviridae)
●
Inactivation: Thermolabile - inactivated in 10
minutes at 50 degrees C and in seconds at
100 degrees C. Susceptible to disinfectants and
detergents
●
Source: Chimpanzees (first transmission to
humans was in the 1800s)
●
Incubation period: 1-6 weeks without
treatment, AIDS develop within 10 years
●
Affected cells/system: CD4+ cells (T
lymphocytes, macrophages)
●
The first cells to be infected by HIV are usually
resident tissue macrophages or submucosal
lymphocytes in the genitals or rectum. From there,
the virus travels to the draining lymph nodes, where
it replicates extensively.
PAGE 29 #PASAR #RN2028 Lord Help Us Pass MICROPARA 〒▽〒MicroPara Lec - Finals
S.Y. 2024 - 2025 | Level I Midyear Term
●
●
●
About 2–3 weeks after infection, most patients may
develop:
○
Uremia
○
A drop in CD4+ T lymphocyte activity
○
A glandular fever-like illness (similar to
mononucleosis)
HIV mainly infects cells that express the CD4
antigen. In the bloodstream, it is found in CD4+
lymphocytes and monocyte-macrophage cells,
which may act as viral reservoirs.
This is followed by a long asymptomatic phase,
lasting from 1 to 15 years. During this phase:
○
Only a small number of CD4+ cells produce the
virus.
○
The virus remains in the blood at low levels
(low titers).
○
Follicular hyperplasia develops in lymphoid
organs.
When the CD4+ T cell count drops below 400/μL,
many variants of the virus spill out from
degenerating lymph nodes into the blood. This sets
the stage for opportunistic infections caused by
various microorganisms.
The causes of death in AIDS include opportunistic
infections, malignancies, and a cachexia-like state
(wasting syndrome).
Reverse transcriptase: what makes this virus unique
since it is what gives the virus the ability to convert RNA
to DNA, allowing it to stay latent in the T lymphocytes
○
Loss of antibody to p24 antigen
CLASSES OF ANTIRETROVIRAL DRUGS
ANTIRETROVIRAL
DRUG ACTION
EXAMPLES
(ANTIRETROVIRAL
DRUGS)
Non-nucleoside
reverse
transcriptase
inhibitors (NNRTIs)
Turn off a protein
needed by HIV
to make copies
of itself.
Efavirenz (Sustiva),
rilpivirine (Edurant)
and doravirine
(Pifeltro)
Nucleoside or
nucleotide reverse
transcriptase
inhibitors (NRTIs)
Faulty versions
of the building
blocks that HIV
needs to make
copies of itself
Abacavir (Ziagen),
Tenofavic
disoproxil
fumarate
(Viride),
emtricitabine
(emtriva),
Iamivudine
(Epivir), and
zidovudine
(Retrovir)
Protease Inhibitors
(PIs)
Inactivate HIV
protease,
another protein
that HIV needs
to make copies
of itself.
Atazanavir (Reyataz),
Darunavirs
(Prezista), and
Iopinavir/ritonavir
(Kaletra)
●
●
●
Symptoms: acute onset fever with or without
night sweats, malaise, headache, myalgia,
arthralgia, lethargy, diarrhea, depression, sore
throat, and skin rash. Spontaneous ulceration
occurs within 1 month.
Asymptomatic infection: Positive HIV antibody
tests, infectious, autoimmune diseases may
occur, persistent generalized lymphadenopathy in
25-50% of asymptomatic patients
Signs of disease progression:
○
Downward trend of CD4+ T cells in successive
samples
○
Ease of virus culture
○
Presence of p24 antigen in plasma
Integrase Inhibitors
Disable
integrase, which
HIV uses to
insert its genetic
material into
CD4 T cells.
Bictegravir sodium/
emtricitabine/
tenofovir alafenamide
fumarate (Biktarvy),
raltegravir (Isentress),
dolutegravir (Trivicay)
and cabotegravir
(Vocabria).
Entry or Fusion
Inhibitors
Block HIV’s entry
into CD4 T cells.
Enfuvirtide (Selzentry)
and maraviroc
(Fuzeon)
PAGE 30 #PASAR #RN2028 Lord Help Us Pass MICROPARA 〒▽〒MicroPara Lec - Finals
S.Y. 2024 - 2025 | Level I Midyear Term
Even though we have all of the antiretroviral drugs, why
is it that HIV is still untreatable?
●
Mainly due to the process of a latent viral reservoir.
During the lifecycle of the virus, HIV integrates into
the host DNA.
●
A subset of integrated HIV provirus rebates
transcriptionally silent, producing neither viral
proteins nor viral protein until reactivation by various
physiologic stimuli.
●
That is why even though based on testing there are
negative results for HIV, the patient must still
continue to take antiretroviral drugs to control the
HIV from waking up.
VIRAL INFECTIONS: DENGUE
●
Virus: Dengue virus (Flaviviridae)
●
Inactivation: Effectively inactivated by heat
treatment at 56 degrees C for at least 30 mins or at
higher temperature. May be inactivated by UV light
exposure at 75cm distance from source for 45 mins
or longer
●
Source: Bite from infected mosquito (Aedes
aegypti)
●
Incubation period: 3-10 days
●
Affected cells/ system: Immune system, Systemic
●
Pathogenesis: 3 phases - febrile, critical
convalescent
●
Treatment and Prevention: vaccine, Supportive
VIRAL INFECTIONS: COVID-19
●
The virus associated with the outbreak originating in
Wuhan, China has been designated severe acute
respiratory syndrome 2 (SARS-CoV-2). The disease
caused by that virus is now officially called
COVID-19.
●
Although SARS CoV-2 is most often spread
person-to-person, the US Food and Drug
Administration issued a safety alert advising that the
virus can also be spread via fecal microbiota
transplants
●
A review of 191 adults hospitalized with COVID-19
in Wuhan found that 91 (48%) had comorbidity.
Hypertension (30%) was most common followed by
diabetes (19%) and coronary heart disease (8%)
VIRAL INFECTIONS: SUMMARY
PAGE 31 #PASAR #RN2028 Lord Help Us Pass MICROPARA 〒▽〒MicroPara Lec - Finals
S.Y. 2024 - 2025 | Level I Midyear Term
WE CAN DO THIS GUYS
me praying na maynta makapasar sa le maski wa nakatuon
tarong
PAGE 32 #PASAR #RN2028 Lord Help Us Pass MICROPARA 〒▽〒